Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2012 Financial Results

Significant Regulatory Approvals
Gained in Fourth Quarter

Eliquis® Approved in the
U.S., Europe, Japan, Canada and South Korea to Reduce the Risk of
Stroke in Patients with Nonvalvular Atrial Fibrillation

Forxiga® Approved in Europe
for...

Source: Drugs.com - Pharma News - January 24, 2013 Category: Pharmaceuticals Source Type: news